<DOC>
<DOCNO>EP-0634398</DOCNO> 
<TEXT>
<INVENTION-TITLE>
4-Phenylpiperidinyl-1/-piperazinyl-1-ethylsubstituted benzofusedheterocycles as antiarrhythmic agents.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K314427	A61K314427	A61K31443	A61K31445	A61K31445	A61K31451	A61K31451	A61K3147	A61K3147	A61K31495	A61K31495	A61P900	A61P906	C07D21100	C07D21114	C07D21118	C07D21122	C07D21126	C07D21128	C07D21134	C07D21500	C07D21512	C07D29500	C07D29504	C07D29508	C07D295096	C07D30700	C07D30781	C07D31300	C07D31308	C07D31900	C07D31918	C07D40100	C07D40106	C07D40500	C07D40506	C07D40514	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61K31	A61P9	A61P9	C07D211	C07D211	C07D211	C07D211	C07D211	C07D211	C07D211	C07D215	C07D215	C07D295	C07D295	C07D295	C07D295	C07D307	C07D307	C07D313	C07D313	C07D319	C07D319	C07D401	C07D401	C07D405	C07D405	C07D405	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Piperidine and piperazine derivatives of the formula I 
<
IMAGE
>
  in which     R
<
1
>
 and R
<
2
>
 are H or A, R
<
3
>
, R
<
4
>
 and R
<
5
>
 in each case independently of one another are H, Hal, OH, OA, OAc, NO2, NH2, NHAc, NHSO2A or CN,  or   R
<
3
>
 and R
<
4
>
 together are also -O-(CH2)m-O-,   n is 0, 1 or 2,   X is O or CH2 if n = 0 or 2, or CH2, NH, NA or NAc if n = 1,   Y is CH or N,   m is 1 or 2,   Hal is F, Cl, Br or I,   A is alkyl having 1-6 C atoms and Ac is alkanoyl having 1-8 C atoms, aralkanoyl having 1-10 C atoms or aroyl having 7-11 C atoms, and their physiologically acceptable salts have antiarrhythmic effects.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
